Hematology/Oncology
RSSArticles
-
Criteria for New Formulary Drugs in PDF
-
Special Feature: Update on COPD Exacerbations: Part II — Management
A recently published study using a large national administrative database found that only two-thirds of patients hospitalized with exacerbations of chronic obstructive pulmonary disease (COPD) received care that was consistent with current guidelines of the American College of Physicians and the American College of Chest Physicians. -
Pharmacology Watch: Raloxifene's Role for Estrogen- and Age-Related Problems
The Truth About Multivitamins; Statins and Hepatitis C; Preventing Hot Flashes; FDA News -
Clinical Briefs in Primary Care supplement
-
Full September 2006 Issue in PDF
-
Putting Therapeutic Hypothermia into Practice
Previous large, randomized studies have demonstrated improved neurological outcome in comatose patients with out-of-hospital cardiac arrest due to ventricular fibrillation (VF) who are managed with therapeutic hypothermia (TH): those with other arrhythmias or shock were excluded. -
Linezolid-Resistant Coagulase-Negative Staphylococci
At the University of Pittsburgh Medical Center, laboratory-based surveillance of coagulase-negative staphylococci found that 4% were linezolid resistant. -
Atrioventricular Nodal Reentrant Tachycardia in Patients with Atrial Fibrillation
In this report, Sauer and colleagues from the University of Pennsylvania describe the prevalence, significance, and management strategy for patients who have AV node reentrant tachycardia (AVNRT) in association with atrial fibrillation (AF). -
Full October 1, 2006 Issue in PDF
-
How Long is Long Enough?
Three days of amoxicillin is as effective as five for mild-to-moderately severe community-acquired pneumonia.